Continuum Advisory’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-46
Closed -$1.61K 1202
2025
Q1
$1.61K Buy
46
+7
+18% +$278 ﹤0.01% 1420
2024
Q4
$1.74K Buy
39
+12
+44% +$539 ﹤0.01% 1461
2024
Q3
$1.26K Buy
+27
New +$1.02K ﹤0.01% 1583

Other funds holding OMCL

Continuum Advisory's OMCL Position: Q2 2025 in Review

Continuum Advisory sold out of Omnicell (OMCL) in Q2 2025, closing a stake of 46 shares — an estimated $1.61K sold.

Continuum Advisory first reported a position in OMCL in Q3 2024 and held it in 3 quarters. The position peaked at $1.74K in Q4 2024. 247 funds tracked by Wall St. Rank hold OMCL as of Q2 2025.

  • Continuum Advisory reported no remaining Omnicell position as of Q2 2025 after selling out during the quarter.
  • Continuum Advisory sold 46 Omnicell shares in Q2 2025, an estimated $1.61K.
  • Continuum Advisory first reported a position in Omnicell in Q3 2024 and held it in 3 quarters.
  • Continuum Advisory's Omnicell position peaked at $1.74K in Q4 2024.
  • 247 funds tracked by Wall St. Rank held Omnicell as of Q2 2025.

Based on Continuum Advisory's 13F filing for Q2 2025, filed 13 Aug 2025.